---
title: "Trupanion Q2 2026 earnings: Subscription growth lifts operating profit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295017424.md"
description: "Trupanion reported Q2 2026 revenue of $392.9 million, up 11% YoY, driven by subscription growth and improved claims economics. Operating income rose to $6.4 million, and adjusted EBITDA increased to $19.8 million. However, diluted EPS fell to $0.16 due to lower non-operating income, which included a prior-year gain from preferred stock exchange. The company authorized a $100 million share repurchase program."
datetime: "2026-08-05T21:15:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295017424.md)
  - [en](https://longbridge.com/en/news/295017424.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295017424.md)
generator: "portal-rs"
---

# Trupanion Q2 2026 earnings: Subscription growth lifts operating profit

Trupanion (NASDAQ: TRUP) reported Q2 2026 revenue of $392.9 million, up 11% from $353.6 million a year earlier, while diluted EPS fell to $0.16 from $0.22. Subscription growth, improved claims economics, and stronger cash generation lifted operating income and adjusted EBITDA, but lower non-operating income reduced GAAP net income.

## Core earnings data

Revenue grew faster than cost of revenue, lifting calculated gross profit by about 19% and expanding gross margin by roughly 1.1 percentage points. Operating expenses increased about 12%, led by higher technology and development and new pet acquisition spending, but the gross-profit increase was sufficient to raise operating income to $6.4 million.

The divergence between higher operating profit and lower net income is important: adjusted EBITDA and cash flow improved, while GAAP earnings were affected by a less favorable year-over-year comparison in non-operating income.

| Metric                      | Q2 2026                | Q2 2025                | YoY change     |
| --------------------------- | ---------------------- | ---------------------- | -------------- |
| Revenue                     | $392.9M                | $353.6M                | Approx. +11.1% |
| Gross profit and margin     | Approx. $65.1M / 16.6% | Approx. $54.8M / 15.5% | Approx. +18.8% |
| Operating income and margin | $6.4M / approx. 1.6%   | $2.3M / approx. 0.7%   | Approx. +176%  |
| Net income                  | $6.8M                  | $9.4M                  | Approx. -27.4% |
| Diluted EPS                 | $0.16                  | $0.22                  | Approx. -27.3% |
| Adjusted EBITDA             | $19.8M                 | $16.6M                 | Approx. +19.4% |
| Operating cash flow         | $21.0M                 | $15.0M                 | Approx. +39.7% |
| Free cash flow              | $19.2M                 | $12.0M                 | Approx. +59.0% |

Gross profit and related margins are calculated as revenue less cost of revenue. Adjusted EBITDA and free cash flow are non-GAAP measures.

## Business and segment performance

The subscription business remained Trupanion’s primary growth driver. Subscription revenue rose faster than enrolled subscription pets, supported by a 9.4% increase in monthly average revenue per pet and slightly higher retention.

The enrollment picture was mixed, however. Subscription pets increased 5%, while total enrolled pets declined 2%, indicating that weakness outside the subscription segment continued to offset part of the core business’s expansion.

| Metric                                              | Q2 2026        | Q2 2025        | YoY change     |
| --------------------------------------------------- | -------------- | -------------- | -------------- |
| Subscription revenue                                | $276.7M        | $242.2M        | Approx. +14.3% |
| Other business revenue                              | $116.2M        | $111.4M        | Approx. +4.3%  |
| Total enrolled pets, period-end                     | 1,633,131      | 1,660,455      | Approx. -1.6%  |
| Subscription pets, period-end                       | 1,124,548      | 1,066,354      | Approx. +5.5%  |
| Monthly average revenue per pet                     | $87.44         | $79.93         | Approx. +9.4%  |
| Average pet acquisition cost                        | $299           | $276           | Approx. +8.3%  |
| Average monthly retention                           | 98.37%         | 98.29%         | +0.08 points   |
| Subscription adjusted operating income and margin   | $41.4M / 15.0% | $33.4M / 13.8% | Approx. +24.0% |
| Other business adjusted operating income and margin | $1.9M / 1.6%   | $1.4M / 1.3%   | Approx. +33.7% |

Within the subscription segment, the non-GAAP cost of paying veterinary invoices declined to 70.2% of revenue from 71.1%. Variable expenses edged down to 9.0% from 9.1%, while allocated fixed expenses fell to 5.8% from 6.0%. These changes supported the 1.2-point expansion in subscription adjusted operating margin.

## Operating improvement was offset by lower non-operating income

Trupanion’s operating income increased from $2.3 million to $6.4 million, but net income declined from $9.4 million to $6.8 million. The difference came mainly from non-operating items rather than deterioration in the underlying business.

Net other income fell to $2.8 million from $11.9 million. The prior-year quarter included a $7.8 million realized gain from the nonmonetary exchange of a preferred stock investment. Although interest expense declined to $1.8 million from $3.7 million, that benefit did not offset the reduction in other income. As a result, pretax income fell to $7.4 million from $10.5 million despite the higher operating profit.

## Cash flow and balance sheet

Cash conversion improved during the quarter. Operating cash flow reached $21.0 million, and $1.8 million of capital expenditures resulted in free cash flow of $19.2 million.

At June 30, 2026, Trupanion held $398.5 million in cash and short-term investments, compared with approximately $370.7 million at the end of 2025. Current and long-term debt totaled $106.9 million, down from $111.8 million at year-end, and the company reported another $3.5 million available under its credit facility.

In July, the New York Department of Financial Services approved a $44 million extraordinary dividend from American Pet Insurance Company to its parent, Trupanion. This is an intercompany payment rather than a dividend to public shareholders. Separately, the board authorized up to $100 million of share repurchases with no expiration date. The authorization does not require any purchases, and the timing will depend on available cash, operating cash flow, credit-facility compliance, market conditions, and alternative uses of capital.

## Management perspective

CEO and President Margi Tooth emphasized margin growth, improving the economics of new enrollments, and disciplined capital allocation. Average pet acquisition cost fell sequentially to $299 from $315 in Q1 2026, although it remained above the $276 reported a year earlier. The margin improvement and stronger free cash flow provide measurable support for the company’s focus on operating efficiency and capital discipline.

## Recent insider transactions

The provided six-month holder data categorized 134,172 shares across 31 transactions as purchases and 39,310 shares across 13 transactions as sales. That produced reported net purchases of 94,862 shares, equal to 1.4% of the 6.87 million total insider shares held.

Seven of the latest ten provided records disclosed both a transaction action and value. Three direct records dated May 22, 2026 lacked those details and are excluded below.

| Date          | Insider and position        | Transaction                                                       | Holding type | Reported value |
| ------------- | --------------------------- | ----------------------------------------------------------------- | ------------ | -------------- |
| Jul. 28, 2026 | John R. Gallagher, COO      | Sale at $25.08 per share                                          | Direct       | $10,809        |
| Jun. 29, 2026 | John R. Gallagher, COO      | Sale at $25.35 per share                                          | Direct       | $10,926        |
| Jun. 5, 2026  | Steve A. Weinrauch, Officer | Sale at $22.00 per share                                          | Direct       | $146,828       |
| Jun. 5, 2026  | Steve A. Weinrauch, Officer | Exercise or conversion of derivative security at $15.46 per share | Direct       | $131,410       |
| May 28, 2026  | John R. Gallagher, COO      | Sale at $21.69 per share                                          | Direct       | $78,153        |
| May 27, 2026  | Fawwad Qureshi, CFO         | Sale at $22.17–$22.62 per share                                   | Direct       | $137,016       |
| May 22, 2026  | Margaret R. Tooth, CEO      | Sale at $21.86 per share                                          | Direct       | $10,733        |

These records describe the transactions but do not, by themselves, establish insiders’ views of Trupanion’s outlook.

## Risks investors should monitor

-   **Enrollment remains uneven.** Subscription enrollment increased, but total enrolled pets declined 2%. Continued contraction outside the subscription business could limit consolidated volume growth.
-   **Acquisition costs increased year over year.** Average pet acquisition cost rose to $299 from $276, while subscription acquisition cost increased to 7.8% of subscription revenue from 7.5%. Further increases could reduce the returns from new-member growth.
-   **Claims economics remain central to margins.** The subscription veterinary-invoice cost ratio improved this quarter, but higher claim severity or frequency—and delays in implementing pricing changes—could reverse that progress.
-   **Technology spending is rising.** Technology and development expense increased to $12.8 million from $8.6 million. These investments could constrain operating leverage if they continue growing faster than revenue without producing corresponding benefits.
-   **Repurchases could affect liquidity.** The $100 million authorization is optional, but actual repurchases would compete with debt reduction, growth investment, and other uses of cash.

## Summary

Trupanion’s Q2 2026 results showed improving underlying operations: subscription revenue and revenue per pet grew, claims costs consumed a smaller share of subscription revenue, and both operating profit and free cash flow increased. GAAP net income declined because the prior-year quarter benefited from a sizable investment-related gain. Investors’ next focus should be whether Trupanion can sustain margin expansion while addressing declining total enrollment and controlling acquisition and technology spending.

Find out more

### Related Stocks

- [TRUP.US](https://longbridge.com/en/quote/TRUP.US.md)

## Related News & Research

- [Trupanion Q2 revenue slightly beats estimates, helped by subscription business strength](https://longbridge.com/en/news/295010450.md)
- [Trupanion (NASDAQ:TRUP) CEO Margaret Tooth Sells 491 Shares of Stock](https://longbridge.com/en/news/297097686.md)
- [Greg Abel-Led Berkshire Hathaway Owns 3 Consumer Stocks. Here's the One I'd Buy First.](https://longbridge.com/en/news/300873098.md)
- [Western Digital vs. Sandisk: The Better Way to Play the Hard-Drive Side of the AI Storage Boom](https://longbridge.com/en/news/300870855.md)
- [Constellation Brands Stock Forecast: Beer Demand Faces a Key Q2 Earnings Test](https://longbridge.com/en/news/300859275.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**